Rescission of Trump-Era Insulin, Epinephrine Rule Moves Forward

The HHS is proposing to a rescind a Trump administration drug rule that required community health centers to pass on all their insulin and epinephrine discount savings to patients.

The proposal to retract the rule is under review at the White House Office of Management and Budget. Once it clears, the Department of Health and Human Services can publish it at any time.

Centers that don’t pass on the savings wouldn’t qualify for federal grants under the rule. The HHS under President Joe Biden had delayed the effective date of the rule (RIN 0906-AB25) until July 20 to ...